Comments for Pharma's Cutting Edge http://www.pharmaweblog.com Pharmaceutical and biotech science and business Fri, 21 Nov 2008 16:11:33 +0000 http://wordpress.org/?v=2.6 http://www.feedburner.comhttp://www.feedburner.com/fb/images/pub/fb_pwrd.gifThis Feed Powered by FeedBurner.comThis is an XML content feed. It is intended to be viewed in a newsreader or syndicated to another site, subject to copyright and fair use. Comment on Revisiting premarketing risk evaluations by FDA finally admits need for large safety studies premarketing | Pharma's Cutting Edge http://www.pharmaweblog.com/2007/05/21/revisiting-premarketing-risk-evaluations/#comment-203 FDA finally admits need for large safety studies premarketing | Pharma's Cutting Edge Thu, 20 Nov 2008 18:56:37 +0000 http://pharmaweblog.com/blog/2007/05/21/revisiting-premarketing-risk-evaluations/#comment-203
This is a content summary only. Visit my blog at http://www.pharmaweblog.com for full content, links and more!
]]> Comment on Acomplia to be pulled in EU by CB1 antagonist update, and a poor excuse | Pharma's Cutting Edge http://www.pharmaweblog.com/2008/10/23/acomplia-to-be-pulled-in-eu/#comment-200 CB1 antagonist update, and a poor excuse | Pharma's Cutting Edge Fri, 07 Nov 2008 18:13:18 +0000 http://www.pharmaweblog.com/?p=580#comment-200
This is a content summary only. Visit my blog at http://www.pharmaweblog.com for full content, links and more!
]]> Comment on Lilly to Massachusetts legislators: your new code stinks by Off-base on off-label promotion | Pharma's Cutting Edge http://www.pharmaweblog.com/2008/09/23/lilly-to-massachusetts-legislators-your-new-code-stinks/#comment-198 Off-base on off-label promotion | Pharma's Cutting Edge Wed, 29 Oct 2008 01:29:26 +0000 http://www.pharmaweblog.com/?p=512#comment-198
This is a content summary only. Visit my blog at http://www.pharmaweblog.com for full content, links and more!
]]> http://api.feedburner.com/awareness/1.0/GetFeedData?uri=PharmasCuttingEdgeComments